Clinical and economic analysis of the use of dapagliflozin in patients with chronic heart failure with reduced left ventricular ejection fraction in various subgroups of standard therapy in the Russian Federation

Aim. To evaluate the clinical and economic effectiveness of dapagliflozin in patients with chronic heart failure (CHF) with reduced left ventricular ejection fraction (HFrEF) in the Russian Federation in various subgroups of standard therapy for CHF. Materials and methods. A clinical and economic...

Descripción completa

Detalles Bibliográficos

Autores principales:	Sergey V. Nedogoda, Marina V. Zhuravleva, Sergey N. Tereshchenko, Alla S. Salasyuk, Igor V. Zhirov, Irina N. Barykina, Viktoria O. Lutova, Ekaterina A. Popova
Formato:	Artigo
Lenguaje:	Russo
Publicado:	"Consilium Medicum" Publishing house 2024-09-01
Colección:	Терапевтический архив
Materias:	chronic heart failure dapagliflozin left ventricular ejection fraction cost-effectiveness analysis pharmacoeconomic modeling
Acceso en línea:	https://ter-arkhiv.ru/0040-3660/article/viewFile/634203/pdf
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!